EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Harnessing cell aggregates for enhanced adeno‐associated virus manufacturing: Cultivation strategies and scale‐up considerations

Brian Ladd iD, Torbjörn Gräslund, Véronique Chotteau

Biotechnology Progress · 2025

DOI: 10.1002/btpr.3522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Progress, 2025. Verfasst von Brian Ladd und 2 weiteren Autor:innen. Beteiligte Einrichtung: AdBIOPRO, VINNOVA Competence Centre for Advanced Bioproduction by Continuous Processing, Royal Institute of Technology (KTH), Stockholm, Sweden. Hauptthemen laut MEDLINE: Dependovirus, Cell Culture Techniques, Virus Cultivation. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: VINNOVA, Horizon 2020 Framework Programme, Cobra Biologics, Science Park University of Keele, Keele, Newcastle ST5 5SP, United Kingdom.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The possibility to produce recombinant adeno‐associated virus (rAAV) by adherent HEK293T cells was studied in a stirred tank bioreactor (STR) culture of cell aggregates. A proof‐of‐concept of rAAV production was successfully demonstrated in a process where single cells were first expanded, then cell aggregates were formed by dilution into a different medium 1 day before triple plasmid transfection was conducted. An alternative approach for the STR inoculation using a seed taken from a high cell density perfusion (HCDP) culture was also investigated. It was, however, found that the spent medium of the HCDP inhibited the transfection of HEK293T cell aggregates, which was confirmed when testing with single‐cell suspension culture. The formation of aggregates in shaken multi‐well plates was also investigated to develop a screening system using the average power input as a scale‐down criterion, which revealed that cell aggregates could be generated in 12‐well plates, however with a larger size than in a STR. Taking into account the reported higher rAAV production of adherent cells in comparison with single cells for triple‐plasmid transfection, HEK293T cell aggregates can possibly surpass single‐cell suspension in space–time rAAV yield. The formation of HEK293T cell aggregates in a STR system offers a promising approach for scaling up and intensifying rAAV production by triple‐plasmid transfection, in comparison with traditional 2D scale‐up methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusCell Culture TechniquesVirus CultivationHumansHEK293 CellsTransfectionBioreactorsCell Aggregation

Stichwörter der Autor:innen

intensificationrAAVscale‐uptransfectionviral vectors

Autor:innen und Institutionen

  • AdBIOPRO, VINNOVA Competence Centre for Advanced Bioproduction by Continuous Processing, Royal Institute of Technology (KTH), Stockholm, Sweden.
  • Department of Industrial Biotechnology, School of Engineering Sciences in Chemistry, Biotechnology and Health, Royal Institute of Technology (KTH), Stockholm, Sweden.
  • Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, Royal Institute of Technology (KTH), Stockholm, Sweden.

ORCID-Profile: Brian Ladd

Förderung

  • VINNOVA
  • Horizon 2020 Framework Programme
  • Cobra Biologics, Science Park University of Keele, Keele, Newcastle ST5 5SP, United Kingdom
  • Cytiva, Björkgatan 30, 753 23 Uppsala

Zitieren

APA

Ladd, B., Gräslund, T., & Chotteau, V. (2025). Harnessing cell aggregates for enhanced adeno‐associated virus manufacturing: Cultivation strategies and scale‐up considerations. Biotechnology Progress. https://doi.org/10.1002/btpr.3522

Vancouver

Ladd B, Gräslund T, Chotteau V. Harnessing cell aggregates for enhanced adeno‐associated virus manufacturing: Cultivation strategies and scale‐up considerations. Biotechnology Progress. 2025. doi:10.1002/btpr.3522

BibTeX
@article{Ladd2025,
  author = {Ladd, Brian and Gräslund, Torbjörn and Chotteau, Véronique},
  title = {Harnessing cell aggregates for enhanced adeno‐associated virus manufacturing: Cultivation strategies and scale‐up considerations},
  journal = {Biotechnology Progress},
  year = {2025},
  doi = {10.1002/btpr.3522}
}
Kostenlos starten →